Chronic myeloid leukaemia (in remission)

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 2
Mechanism of action (INN-stem analysis)
Kinase inhibitor 3 substances
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Heidelberg University Academic
    NILOTINIB
    2024-519472-69-00 1 country n=75
    Pending
  • Masarykova Univerzita Academic
    DASATINIB; IMATINIB; NILOTINIB
    2024-514592-17-00 1 country 2020 n=221
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Heidelberg University Academic 1 Phase II 0
Masarykova Univerzita Academic 1 Phase II 0
New trials by year
2020
1
← All indication landscapes